Metagenomic fingerprints in bronchoalveolar lavage differentiate pulmonary diseases.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 41057624.
- Also identified by DOI 10.1038/s41746-025-01977-5 and PMC identifier 12504733.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent advances in unbiased metagenomic next-generation sequencing (mNGS) enable simultaneous examination of microbial and host genetic material. We developed a multimodal machine learning-based diagnostic approach to differentiate lung cancer and pulmonary infections by analyzing 402 bronchoalveolar lavage fluid (BALF) mNGS datasets, including lung cancer (n = 123), bacterial infections (n = 114), fungal infections (n = 79), and pulmonary tuberculosis (n = 86). The training cohort revealed differences in microbial profiles, bacteriophage abundance, host gene and transposable element expression, immune cell composition, and tumor fraction derived from copy number variation (CNV). The integrated model (Model VI) achieved an AUC of 0.937 (95% CI, 0.910-0.964) in the training cohort and 0.847 (95% CI, 0.776-0.918) in the test cohort. A rule-in/rule-out strategy further improved accuracy in differentiating lung cancer from tuberculosis (accuracy = 0.896), fungal (accuracy = 0.915), and bacterial (accuracy = 0.907) infections. These findings highlight the potential of mNGS-based multimodal analysis as a cost-effective tool for early and accurate differential diagnosis.